Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CeluRay is a standardized celery seed extract developed by Indus Biotech (Indus Group) as a nutraceutical ingredient for dietary supplements. It is standardized to contain at least 42.5% total phthalides, including 3-n-butylphthalide (3nB), sedanolide, and other phthalide compounds. These phytochemicals are associated with various health benefits, including the promotion of cardiovascular health through improved blood circulation, joint health support, and the management of chronic hyperuricemia. CeluRay exhibits antioxidant, anti-inflammatory, diuretic, and neuroprotective properties. It is intended for oral administration and is used as a component in various supplement formulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CeluRay.